These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 26383688)

  • 41. Reply to D. Adkins et al.
    Psyrri A; Economopoulou P; Dafni U
    J Clin Oncol; 2015 Apr; 33(10):1225-6. PubMed ID: 25713435
    [No Abstract]   [Full Text] [Related]  

  • 42. Reply to D. Adkins et al.
    Axelrod RS; Sherman E; Garden A; Nguyen-Tan PF; Trotti A; Yom SS; Zhang Q
    J Clin Oncol; 2015 Apr; 33(10):1224-5. PubMed ID: 25713438
    [No Abstract]   [Full Text] [Related]  

  • 43. Neoadjuvant docetaxel and cisplatin chemotherapy followed by local irradiation is highly active on locoregionally advanced squamous cell carcinoma of the head and neck.
    Shin HJ; Chung JS; Choi YJ; Lee BJ; Wang SG; Kim DW; Cho GJ
    J Laryngol Otol; 2008 Jul; 122(7):722-7. PubMed ID: 17925058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidermal growth factor receptor targeting in head and neck cancer: have we been just skimming the surface?
    Hansen AR; Siu LL
    J Clin Oncol; 2013 Apr; 31(11):1381-3. PubMed ID: 23460713
    [No Abstract]   [Full Text] [Related]  

  • 45. [Planned neck dissection in the treatment of locally advanced head and neck squamous cell carcinoma].
    Jiang L; Lou JL; Wang KJ; Fang MY; Fu ZF
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):92-96. PubMed ID: 29429177
    [No Abstract]   [Full Text] [Related]  

  • 46. Concurrent chemoradiotherapy with cisplatin and docetaxel for head and neck squamous cell carcinoma.
    Kumai T; Komatsuda H; Wakisaka R; Yamaki H; Kono M; Hayashi R; Kishibe K; Takahara M; Katada A; Hayashi T; Harabuchi Y
    Clin Otolaryngol; 2022 Jan; 47(1):228-233. PubMed ID: 34657397
    [No Abstract]   [Full Text] [Related]  

  • 47. Combining cetuximab with chemoradiotherapy in locally advanced head and neck squamous cell carcinoma: is more better?
    Psyrri A; Dafni U
    J Clin Oncol; 2014 Sep; 32(27):2929-31. PubMed ID: 25002730
    [No Abstract]   [Full Text] [Related]  

  • 48. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.
    Mesía R; Garcia-Saenz JA; Lozano A; Pastor M; Grau JJ; Martínez-Trufero J; Lambeaz J; Martínez-Galán J; Mel JR; González B; Vázquez S; Mañós M; Taberna M; Cirauqui B; Del Barco E; Casado E; Rubió-Casadevall J; Rodríguez-Jaráiz A; Cruz JJ;
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):473-480. PubMed ID: 28011050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug therapy: Cetuximab or cisplatin in HNSCC?
    Hutchinson L
    Nat Rev Clin Oncol; 2016 Feb; 13(2):66. PubMed ID: 26718111
    [No Abstract]   [Full Text] [Related]  

  • 50. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.
    Ghi MG; Paccagnella A; D'Amanzo P; Mione CA; Fasan S; Paro S; Mastromauro C; Carnuccio R; Turcato G; Gatti C; Pallini A; Nascimben O; Biason R; Oniga F; Medici M; Rossi F; Fila G
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):481-7. PubMed ID: 15145166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comment on Dornoff et al.: Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck.
    Müller K; Klautke G
    Strahlenther Onkol; 2015 Dec; 191(12):985. PubMed ID: 26475340
    [No Abstract]   [Full Text] [Related]  

  • 52. Reply to: Comment on Dornoff et al.: Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck.
    Balermpas P
    Strahlenther Onkol; 2015 Dec; 191(12):986. PubMed ID: 26475339
    [No Abstract]   [Full Text] [Related]  

  • 53. Can erlotinib ameliorate cisplatin-induced toxicities?
    Sprowl JA; Mathijssen RH; Sparreboom A
    J Clin Oncol; 2013 Sep; 31(27):3442-3. PubMed ID: 23960178
    [No Abstract]   [Full Text] [Related]  

  • 54. RTOG 0522: huge Investment in patients and resources and no benefit with addition of cetuximab to radiotherapy--why did this occur?
    Adkins D; Ley J; Wildes TM; Michel L
    J Clin Oncol; 2015 Apr; 33(10):1223-4. PubMed ID: 25713440
    [No Abstract]   [Full Text] [Related]  

  • 55. Radiochemotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer.
    Schäfer C; Dietl B; Kölbl O
    Br J Cancer; 2006 May; 94(10):1544-5; author reply 1546-7. PubMed ID: 16705316
    [No Abstract]   [Full Text] [Related]  

  • 56. [The most important study results of primary chemoradiation for head and neck squamous cell carcinoma : highlights of the ASCO Meeting 2013].
    Münscher A; Busch CJ; Schafhausen P; Tribius S; Knecht R
    HNO; 2013 Nov; 61(11):905-10. PubMed ID: 24221218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Panitumumab for locally advanced head and neck squamous-cell carcinoma.
    Ishiki H; Iwase S; Shimada N; Chiba T; Imai K
    Lancet Oncol; 2015 Apr; 16(4):e156. PubMed ID: 25846092
    [No Abstract]   [Full Text] [Related]  

  • 58. Chlamydia trachomatis infection: possible cofactor for oropharyngeal cancer development?
    Jenkins WD; LeVault K; Sutcliffe S
    Oral Oncol; 2015 Feb; 51(2):e8-9. PubMed ID: 25500096
    [No Abstract]   [Full Text] [Related]  

  • 59. [Multimodality and interdisciplinarity in cancer therapy : highlights of the ASCO Meeting 2013].
    Knecht R
    HNO; 2013 Nov; 61(11):904. PubMed ID: 24221217
    [No Abstract]   [Full Text] [Related]  

  • 60. North-South Divide: Chemo-Immunotherapy Combination in Head and Neck Squamous Cell Cancer (HNSCC).
    Boon IS; Boon CS; Oguejiofor K; Ramkumar S
    Clin Oncol (R Coll Radiol); 2024 Jun; 36(6):e169. PubMed ID: 38565459
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.